Absci (ABSI) Other Non Operating Income (2020 - 2026)
Absci's (ABSI) quarterly Other Non Operating Income came in at $1.3 million in Q1 2026, down 12.0% year-on-year from $1.5 million in Q1 2025, and down 4.68% quarter-over-quarter from $1.3 million in Q4 2025.
Absci (ABSI) Other Non Operating Income (2020 - 2026) Analysis & Trends
Absci has disclosed Other Non Operating Income across 7 years of filings, most recently posting $1.3 million for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $1.3 million, down 12.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.2 million (down 15.04% YoY), and the FY2025 annual result was $5.4 million, down 15.66% from the prior year.
- Other Non Operating Income came in at $1.3 million for Q1 2026 at Absci, down from $1.3 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q2 2024 to a low of $125000.0 in Q1 2022.
- The 5-year median for Other Non Operating Income is $1.4 million (2023), against an average of $1.3 million.
- Across the five-year window, Other Non Operating Income surged 1066.4% in 2023 and tumbled 52.33% in 2025, its largest moves.
- Absci's Other Non Operating Income stood at $1.4 million in 2022, then gained by 2.63% to $1.4 million in 2023, then plunged by 36.31% to $921000.0 in 2024, then jumped by 46.15% to $1.3 million in 2025, then retreated by 4.68% to $1.3 million in 2026.
- The last three Other Non Operating Income figures came in at $1.3 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 921,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.57 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 675,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 188,000.00 |
| Sep 30, 2021 | -3.43 Mn |
| Jun 30, 2021 | -28.11 Mn |